Center for Continuing Education
About The Cleveland Clinic Center for Continuing Education | Call or Email Us | About The Cleveland Clinic
Live Cleveland Clinic CME Courses |  Regularly Scheduled Series (RSS) Registration | Regulary Scheduled Series (RSS) Schedule (pdf)
Disease Management Project Clinical Decisions Cases |  Hepatitis C Management |  Managing Problem Patients with Anti-TNF Inhibitors |  More
Medicine Today Series |  B Cell Series |  Emerging Therapies in Heart Disease Webcast Series |  More
Disease Management Project |  CCJM 1-Minute Consult |  Pharmacotherapy Update Newsletter |  Algorithms for the MICU |  More
Cleveland Clinic Foundation CME Home Contact Us Live CME Courses Online CME Topics Webcasts Online Medical Publications my CME Search Sitemap e-mail Newsletter

Mandy C. Leonard, Pharm.D., BCPS
 Drug Information Specialist
 Editor

Meghan K. Lehmann, Pharm.D., BCPS
 Drug Information Specialist
 Editor

Dana L. Travis, R.Ph.
 Drug Information
  Pharmacist
 Editor

David White, B.S., R.Ph.
 Restricted Drug Pharmacist
 Associate Editor

Marcia J. Wyman, Pharm.D.
 Drug Information
  Pharmacist
 Associate Editor

Amy T. Sekel, Pharm.D.
 Drug Information
  Pharmacist
 Associate Editor

David Kvancz, M.S., R.Ph., FASHP
 Chief Pharmacy Officer

Morton Goldman, Pharm.D., BCPS
 Assistant Director, Pharmacotherapy Services

 

 

 

 

Download Adobe Acrobat Reader
- to read / print PDF files

November/December 2007

Update: Erythropoiesis-Stimulating Agents, Part II
(PDF file 109 KB)
Ambar Khan, Pharm.D., BCOP

September/October 2007

Update: Erythropoiesis-Stimulating Agents, Part I
(PDF file 122 KB)
Amy T. Sekel, Pharm.D.

July/August 2007

NovoSeven®: Cleveland Clinic Guidelines
(PDF file 145 KB)
Pam Risko, Pharm.D.

May/June 2007

Aliskiren (Tekturna®) for Hypertension
(PDF file 136 KB)
Kelli Branch, Pharm.D. Candidate

March/April 2007

Ceprotin™ FDA-Approved for Treatment of Rare Clotting Disorder
(PDF file 121 KB)
Abby E. Kusnerik, Pharm.D. Candidate

January/February 2007

Use of Inhaled Human Insulin in Patients with Diabetes Mellitus
(PDF file 167 KB)
Linda Ghobrial, Pharm.D.

November/December 2006

Prophylaxis Against Human Papillomavirus Infections with Gardasil® Vaccine(PDF file 132 KB)
Jaime Anderson, Pharm.D.

September/October 2006

Osteonecrosis of the Jaw Associated with the Use of Bisphosphonates: Part II(PDF file 208 KB)
Kathryn B. Nguyen, Pharm.D.

July/August 2006

Osteonecrosis of the Jaw Associated with the Use of Bisphosphonates: Part I (PDF file 180 KB)
Kathryn B. Nguyen, Pharm.D.

May/June 2006

Medications Used for Smoking Cessation (PDF file 317 KB)
Mandy Leonard, Pharm.D., BCPS

March/April 2006

2005 Changes to the American Heart Association Guidelines for Cardiopulmonary Resuscitation (PDF file 148 KB)
Heather Bockheim, Pharm.D.

January/February 2006

Pharmocogenomics (PDF file 1.33 MB)
Jessica Dusky, Pharm.D. Candidate

November/December 2005

Pregabalin (Lyrica®): Part II(PDF file 326 KB)
Chadrick Lowther, Pharm.D.

September/October 2005

Pregabalin (Lyrica®): Part I
Chadrick Lowther, Pharm.D.

July/August 2005

Prevention of Meningococcal Disease
Phil Chung, Pharm.D.

May/June 2005

The Cleveland Clinic Foundation's Recommendations for Cyclooxygenase-2 Inhibitor Use
Meghan K. Lehmann, Pharm.D.

March/April 2005

New Therapies for the Treatment of Overactive Bladder
Abigail Bridger, Pharm.D.

January/February 2005

Emerging Therapies in the Treatment of Type 2 Diabetes
Marc A. Earl, Pharm.D.

November/December 2004

Fosphenytoin (Cerebyx®)
Tyrone Lin, Pharm.D.

Did You Know...
Acamprosate calcium (Campral®)

September/October 2004

Duloxetine (Cymbalta®)
Ian Hollis, Pharm.D Candidate

Did You Know....
New Formulations of Fenofibrate for the Treatment of Primary Hypercholesterolemia or Mixed Dyslipidemia

July/August 2004

Daptomycin (Cubicin™): A New Treatment Option for Gram-Positive Infections
Amy Hirsch, Pharm.D.

The Cleveland Clinic Foundation Pharmacy and Therapeutics Committee Automatic Therapeutic Interchange Program Epoetin alfa (Procrit®) to Darbepoetin alfa (Aranesp™)

AB-Rated Oral Contraceptives

May/June 2004

Namenda™ (Memantine) for Moderate-to-Severe Alzheimer's Disease
Shannon Just, Pharm.D.

Spiriva® HandiHaler® (Tiotropium) - A New Therapy for COPD
Katie Milner, Pharm.D.

March/April 2004

New Competition for Viagra®
Christina Collins, Pharm.D. Candidate

Seasonale® (levonorgestrel 0.15 mg/ethinyl estradiol 0.03 mg) Extended-Cycle Oral Contraception
Amy Decker, Pharm.D. Candidate

January/February 2004

Omalizumab: A New Treatment for the Management of Asthma
Bridgette L. Sims, Pharm.D. Candidate

November/December 2003

Rosuvastatin: A New Pharmacotherapy for LDL-Cholesterol Reduction
Katie E. Meister, Pharm.D.

September/October 2003

Intravenous Pantoprazole (Protonix®)
Jeffrey Bruno, Pharm.D.

July/August 2003

New Antifungal Agents: Additions to the Existing Armamentarium (Part 2)
Jennifer Long, Pharm.D., BCPS

May/June 2003

New Antifungal Agents: Additions to the Existing Armamentarium (Part I)
Jennifer Long, Pharm.D., BCPS

March/April 2003

The Safety of Ephedra and Related Alkaloids
Amy Dickson, Pharm.D. Candidate

Ezetimibe (Zetia™)
Bernadette A. Clark, Pharm.D. Candidate

January/February 2003

Ziprasidone Mesylate Injection
Marcia Wyman, Pharm.D.

Dietary Supplements Update: Seals-of-Approval

Enoxaparin Clinical Pearl
Jeff Ketz, Pharm.D., BCPS

November/December 2002

5-HT3 Receptor Antagonists and ECG Effects
Mandy C. Leonard, Pharm.D., BCPS and Michael A. Militello, Pharm.D., BCPS

September/October 2002

Ginkgo Biloba and Memory
Andreea Popa, Pharm.D.

July/August 2002

A Review of Coagulation Products Used in the Treatment of Hemophilia
Nadine Chehab, Pharm.D.

Irritable Bowel Syndrome: Two Drug Options

March/April 2002

Bosentan (Tracleer™), a New Agent for the Treatment of Pulmonary Arterial Hypertension
Andreea Popa, Pharm.D. Candidate

January/February 2002

Drotrecogin alfa-Recombinant Human Activated Protein C (Xigris™)
Jeffrey P. Gonzales, Pharm.D.

November/December 2001

New Oral Antiepileptic Agents
Rhonda Rhea, Pharm.D.

Drug Shortages

September/October 2001

Type II Heparin-Induced Thrombocytopenia: New Treatment Options
Robert Barcelona, Pharm.D.

July/August 2001

Esomeprazole (Nexium™): A New Proton Pump Inhibitor
Mandy Leonard, Pharm.D., BCPS

Galantamine: Did You Know?

May/June 2001

A Review of Oral Antidiabetic Agents
Jeff Ketz, Pharm.D., BCPS

Ziprasidone: Did You Know?

Medication Safety Alert: Advair™Diskus®

March/April 2001

Interactions Between Herbs and Cardiac Medications
Mandy C. Leonard, Pharm.D., BCPS

Nateglinide (Starlix®)

January/February 2001

Tenecteplase (TNKase™): A Clinical Review
Michael Militello, Pharm.D., BCPS

Allergic Reactions to Local Anesthetics

November/December 2000

Concerta™ for Attention-Deficit/Hyperactivity Disorder
Margaret Peters, Pharm.D.

Glucovance™, a combination oral antihyperglycemic agent, wins FDA approval
Kristina Pascuzzi, Pharm.D. student

September/October 2000

Dofetilde: A New Class III Antiarrhythmic
Jodie Zalewski, Pharm.D.

Submitting Research Protocols to the Institutional Review Board
Kenneth Shermock, Pharm.D.

July/August 2000

New FDA-Approved Indications for Risedronate
Marcia Wyman, Pharm.D. Candidate

May/June 2000

Cisapride Withdrawal Requires Alternative Therapy
Jodie M. Zalewski, Pharm.D.

Alosetron: A New Agent for the Treatment of Irritable Bowel Syndrome

November/December 1999

The General Use of Medications in Pregnancy
Christina H. Stack, R. Ph., Pharm.D. Candidate